Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis

Journal of the American Academy of Dermatology

Volumn 42, Issue 3, 2000, Pages 428-435

  Gottlieb, Alice ^a   Krueger, James G ^b   Bright, Ross ^c   Ling, Mark ^d   Lebwohl, Mark ^e   Kang, Sewon ^f   Feldman, Steve ^g   Spellman, Mary ^h   Wittkowski, Knut ^b   Ochs, Hans D ⁱ   Jardieu, Paula ^j   Bauer, Robert ^k   White, Mark ^j   Dedrick, Russell ^k   Garovoy, Marvin ^k  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c Psoriasis Research Institute   (United States)

^d EMORY UNIVERSITY   (United States)

^e MOUNT SINAI MEDICAL CENTER   (United States)

^f UNIVERSITY OF MICHIGAN   (United States)

^g UNIVERSITY OF NORTH CAROLINA   (United States)

^h VRG Inc   (United States)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

^j GENENTECH INC   (United States)

^k XOMA Corporation   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ARTICLE; CHILL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEVER; HEADACHE; HISTOPATHOLOGY; HUMAN; INFECTION; MULTICENTER STUDY; NAUSEA; PAIN; PRIORITY JOURNAL; PRURITUS; PSORIASIS; SKIN BIOPSY; TREATMENT OUTCOME;

EID: 12944283147     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(00)90214-7     Document Type: Article

References (18)

1. Gottlieb AB, Lifshitz B, Fu SM, Staiano-Coico L, Wang CY, Carter DM. Expression of HLA-DR molecules by keratinocytes and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques. J Exp Med 1986;164:1013-28.
2. Gottlieb AB, Krueger JG. The role of activated T lymphocytes in the pathogenesis of psoriasis. In: Dubertret L, editor. Psoriasis. Brescie, Italy: ISED Press; 1994.p.63.
3. Krueger JG, Wolfe JT, Nabeya RT, Vallat VP, Gilleaudeau P, Heftler NS, et al. Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med 1995; 182:2057-68.
4. 389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nat Med 1995;1:442-7.
5. Springer TA. Adhesions receptors of the immune system. Nature 1990;346:425-34.
6. June CH, Ledbetter JA, Linsley PS, Thompson CB. Role of the CD28 receptor in T-cell activation. Immunol Today 1990;11:211-6.
7. Abrams JR, Lebwohl MG, Guzzo CA, Jegasothy BV, Goldfarb MT, Goffe BS, et al. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J Clin Invest 1999;103: 1243-52.
8. vanNoesel C, Miedema F, Brouwer M, deRie MA, Aarden LA, vanLier RAW. Regulatory properties of LFA-1 alpha and beta chains in human T-lymphocyte activation. Nature 1988;333: 850-2.
9. Frederiksson T, Pettersson U. Severe psoriasis: oral therapy with a new retinoid. Dermatologica 1978;157:238-44.
10. Ochs DH, Nonoyama S, Farrington ML, Fischer SH, Aruffo A. The role of adhesion molecules in the regulation of antibody responses. Semin Hematol 1993;30:72-81.
11. Gottlieb AB, Krueger J, Lebwohl M, Gisoldi E, Grossman RM, Wacholtz MC. A multiple dose randomized double-blind placebo-controlled study to determine the efficacy and safety of a humanized anti-CD4 monoclonal antibody in the treatment of moderate to severe chronic psoriasis vulgaris [abstract]. J Invest Dermatol 1998;110:678.
12. Kirk RE. Experimental design: procedures for the behavioural sciences, anonymous. Belmont (CA): Brooks/Cole; 1999.
13. Wittkowski KM. Friedman-type statistics and consistent multiple comparisons for unbalanced designs. J Am Stat Assoc 1988; 83:1163-70.
14. Wittkowski KM. An extension to Wittkowski. J Am Stat Assoc 1992;87:259.
15. Student. On the probability error of a mean. Biometrika 1908;6:1-25.
16. Maglavy D, Mant T, Norman P, Krueger G, Griffiths C, Ellis C, et al. Pharmacodynamic effects of LFA3TIP (Amevive) in patients with chronic plaque psoriasis (CPP): selective modulation of CD45RO+ lymphocytes [abstract]. J Invest Dermatol 1999;112: 609.
17. Asadullah K, Sterry W, Stephanek K, Jasulaitis D, Leupold M, Audring G, et al. IL-10 is a key cytokine in psoriasis: proof of principle by IL-10 therapy, a new therapeutic approach. J Clin Invest 1998;101:783-94.
18. Trepicchio W, Ozawa M, Walters IB, Kikuchi T, Schwertsclag U, Dorner A, et al. IL-11 is an immune-modulatory cytokine which downregulates IL-12, type 1 cytokines, and multiple inflammation-associated genes in patients with psoriasis [abstract]. J Invest Dermatol 1999;112:598.